Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024

Abstract
Apex Market Research has published a new report titled ”Global Interventional Oncology Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global Interventional Oncology market is estimated to grow from USD 2 billion in 2019 to USD 2.9 billion by 2024, at a CAGR of 6.8%. The report offers in-depth insights, revenue details, and other vital information regarding the global Interventional Oncology market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Interventional Oncology market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Interventional Oncology market report offers in-depth insights, revenue details, and other vital information regarding the global Interventional Oncology market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Interventional Oncology market. The major players operating into Interventional Oncology Market include: The major players in the market include Medtronic (Ireland)
Boston Scientific (US)
BTG plc (UK)
Merit Medical Systems (US)
and Terumo (Japan). The other prominent players operating in the overall interventional oncology market include AngioDynamics (US)
Ethicon (part of J&J) (US)
Teleflex (US)
Cook Medical (US)
HealthTronics (US)
MedWaves Medical (US)
Sanarus (US)
IMBiotechnologies (Canada)
Trod Medical (US)
IceCure Medical (Israel)
Mermaid Medicals (Denmark)
and Interface Biomaterials BV (Netherlands)
among others. Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Value (USD)
Covered Segments Products, Procedure, Cancer Type, and Region
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Interventional Oncology market to forecast revenues and analyze trends in each of the following submarkets:

Interventional Oncology Market, by Procedure

  • Thermal Tumor Ablation
  • Non-thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization (TACE)
  • Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
  • Transcatheter Arterial Embolization (TAE) or Bland Embolization

Interventional oncology Market, by Cancer Type

  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancers
By geography, this market has been segregated into five regions with revenue and growth rate of Interventional Oncology from 2020 to 2027,
There are 13 chapters to put on view for Interventional Oncology Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Interventional Oncology Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Interventional Oncology Market Overview 1.1.1 Interventional Oncology Product Scope 1.1.2 Market Status and Outlook 1.2 Global Interventional Oncology Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Interventional Oncology Market Status and Outlook 1.2.2 EU Interventional Oncology Market Status and Outlook 1.2.3 Japan Interventional Oncology Market Status and Outlook 1.2.4 China Interventional Oncology Market Status and Outlook 1.2.5 India Interventional Oncology Market Status and Outlook 1.2.6 Southeast Asia Interventional Oncology Market Status and Outlook 1.3 Global Interventional Oncology Market Segment Interventional Oncology Market, by Procedure
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.1 Thermal Tumor Ablation
1.3.1.1 Market Estimates And Forecast By Country, 2015-2027
1.3.2 Non-thermal Tumor Ablation
1.3.2.1 Market Estimates And Forecast By Country, 2015-2027
1.3.3 Transcatheter Arterial Chemoembolization (TACE)
1.3.3.1 Market Estimates And Forecast By Country, 2015-2027
1.3.4 Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
1.3.4.1 Market Estimates And Forecast By Country, 2015-2027
1.3.5 Transcatheter Arterial Embolization (TAE) or Bland Embolization
1.3.5.1 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Interventional Oncology Market Segment Interventional oncology Market, by Cancer Type
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.1 Liver Cancer
1.4.1.1 Market Estimates And Forecast By Country, 2015-2027
1.4.2 Kidney Cancer
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Lung Cancer
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Bone Cancer
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4.5 Other Cancers
1.4.5.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Interventional Oncology Competition Analysis by Players 2.1 Global Interventional Oncology Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 The major players in the market include Medtronic (Ireland) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 The major players in the market include Medtronic (Ireland), Interventional Oncology Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Boston Scientific (US) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Boston Scientific (US), Interventional Oncology Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 BTG plc (UK) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 BTG plc (UK), Interventional Oncology Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Merit Medical Systems (US) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Merit Medical Systems (US), Interventional Oncology Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 and Terumo (Japan). The other prominent players operating in the overall interventional oncology market include AngioDynamics (US) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 and Terumo (Japan). The other prominent players operating in the overall interventional oncology market include AngioDynamics (US), Interventional Oncology Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Ethicon (part of J&J) (US) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Ethicon (part of J&J) (US), Interventional Oncology Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Teleflex (US) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Teleflex (US), Interventional Oncology Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Cook Medical (US) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Cook Medical (US), Interventional Oncology Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 HealthTronics (US) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 HealthTronics (US), Interventional Oncology Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 MedWaves Medical (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 MedWaves Medical (US), Interventional Oncology Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Interventional Oncology Market Size Type (2015-2019) 4.1 Global Interventional Oncology Market Size by Type (2015-2019) Chapter 5 Global Interventional Oncology Market Size Application (2015-2019) 5.1 Global Interventional Oncology Market Size by Application (2015-2019) 5.2 Potential Application of Interventional Oncology in Future 5.3 Top Consumer / End Users of Interventional Oncology Chapter 6 North America Interventional Oncology Development Status and Outlook 6.1 North America Interventional Oncology Market Size (2015-2019) 6.2 North America Interventional Oncology Market Size by Application (2015-2019) Chapter 7 EU Interventional Oncology Development Status and Outlook 7.1 EU Interventional Oncology Market Size (2015-2019) 7.2 EU Interventional Oncology Market Size by Application (2015-2019) Chapter 8 Japan Interventional Oncology Development Status and Outlook 8.1 Japan Interventional Oncology Market Size (2015-2019) 8.2 Japan Interventional Oncology Market Size by Application (2015-2019) Chapter 9 China Interventional Oncology Development Status and Outlook 9.1 China Interventional Oncology Market Size and Forecast (2015-2019) 9.2 China Interventional Oncology Market Size by Application (2015-2019) Chapter 10 India Interventional Oncology Development Status and Outlook 10.1 India Interventional Oncology Market Size and Forecast (2015-2019) 10.2 India Interventional Oncology Market Size by Application (2015-2019) Chapter 11 Southeast Asia Interventional Oncology Development Status and Outlook 11.1 Southeast Asia Interventional Oncology Market Size and Forecast (2015-2019) 11.2 Southeast Asia Interventional Oncology Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Interventional Oncology Market Size (Million USD) by Regions (2020-2027) 12.1. North America Interventional Oncology Revenue and Growth Rate (2020-2027) 12.1.2 EU Interventional Oncology Revenue and Growth Rate (2020-2027) 12.1.3 China Interventional Oncology Revenue and Growth Rate (2020-2027) 12.1.4 Japan Interventional Oncology Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Interventional Oncology Revenue and Growth Rate (2020-2027) 12.1.6 India Interventional Oncology Revenue and Growth Rate (2020-2027) 12.2 Global Interventional Oncology Market Size by Application (2020-2027) Chapter 13 Interventional Oncology Market Dynamics 13.1 Interventional Oncology Market Opportunities 13.2 Interventional Oncology Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Interventional Oncology Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Interventional Oncology Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
2109

1051

OUR CLIENT